GILD

Gilead Sciences, Inc.

Healthcare›Drug Manufacturers - General|NASDAQ Global Select|US

Price

$139.71

Market Cap

$173.44B

Beta

0.40

P/E

20.5

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+2.40%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+2.57%

P/E Ratio20.5

PEG Ratio0.04

FCF Yield+5.45%

Debt / Equity1.09

Interest Coverage10.7x

No credit card required

Already have an account? Sign in to view the full analysis for GILD.